David Einhorn

David Einhorn

Last Update: 08-14-2017

Number of Stocks: 33
Number of New Stocks: 7

Total Value: $6,198 Mil
Q/Q Turnover: 10%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

David Einhorn Watch

  • David Einhorn Starts Hewlett Packard Enterprise Position in 2nd Quarter

    David Einhorn (Trades, Portfolio), president of Greenlight Capital, seeks long-term capital appreciation through investments that have the potential to achieve consistent returns and safeguard capital. During the second quarter, the activist investor entered a position in Hewlett Packard Enterprise Co. (NYSE:HPE) and eliminated four positions from his portfolio: Time Warner Inc. (NYSE:TWX), Liberty Global PLC (NASDAQ:LBTYK), Syngenta AG (NYSE:SYT) and Cigna Corp. (NYSE:CI).

    Hewlett Packard Enterprise


  • Dislocations Create Fine Opportunities

    “… an investment approach that emphasizes intrinsic value will achieve consistent absolute returns and safeguard capital regardless of market conditions.” -David Einhorn


  • The Tesla vs. GM Battle Continues in Greenlight Capital's 2nd-Quarter Letter

    David Einhorn (Trades, Portfolio)’s second-quarter 2017 letter is out. In it, he comments on both his long General Motors Co. (NYSE:GM) position and his short Tesla Inc. (NASDAQ:TSLA) position. The full letter is embedded below. He broke up the commentary on purpose as it is not intended to be a pair trade, although it could be one. Quoted from the letter, emphasis mine:


  • The Car Company Beating Tesla

    Electric car company Tesla (NASDAQ:TSLA) has taken center stage this year, with the drama of high returns, sudden stock tumbles and short-seller pontifications. But in the past two years, a traditional, fossil-fuel-loving, luxury car company, Ferrair (NYSE:RACE), has raced past the one promising to redefine the future on a long- and short-term basis.

    Ferrari celebrated its 70th anniversary this year, and it began trading on the New York Stock Exchange in October 2015. The IPO came before its January 2016 spin-off from Fiat S.p.A., which owned 90% of its shares since 1988. Sergio Marchionne, the chairman and CEO, joined Fiat S.p.A. in 2004 and was instrumental in the merger between Fiat Group and Chrysler Group in 2009. Its CFO, Allessandro Gili, held positions with Fiat from 2002 to 2014 before advancing to his role at Ferrari in 2015.


  • Rite Aid: A David Einhorn Bargain Stock

    The merger between Rite Aid Corp. (NYSE:RAD) and Walgreens Boots Alliance Inc. (NASDAQ:WBA) disintegrated over the last six months, with the deal finally being called off in June. The company remains open and operating. Rite Aid still plans to sell 2,186 stores - about half of its locations - to Walgreens for $5.2 billion, using those proceeds in addition to the $325 million termination fee to pay down $7 billion in debt that has been crushing the balance sheet for years.

    The company will still generate well over $15 billion in sales, likely at better margins, by focusing on key East and West coast locations, with a large presence in California (577 stores) and Pennsylvania (535 stores) to build upon. When news of that deal closing hits the wire, the stock will have a momentary spike, yet longer term is where my focus remains.


  • David Einhorn Sells Apple, Time Warner, FMC

    David Einhorn (Trades, Portfolio) is president of Greenlight Capital (a value-oriented investment adviser). He manages a portfolio composed of 37 stocks with a total value of $7.195 billion. During the first quarter the guru sold shares in the following stocks:

    The investor reduced his Apple Inc. (AAPL) position by 31.63% with an impact of -3.66% on the portfolio.


  • Mason Hawkins Buys Consol Energy, Viasat, Sonic

    Mason Hawkins (Trades, Portfolio) has been chairman and CEO of Southeastern Asset Management since 1975, and he and his partners manage the Longleaf Partners Funds. He manages a portfolio composed of 92 stocks with a total value of $9.839 billion. During the first quarter the guru bought shares in the following stocks:

    The stake in Consol Energy Inc. (CNX) was raised by 12.47% with an impact of 0.95% on the portfolio.


  • David Einhorn Comments on General Motors Company

    While it was quiet on the portfolio front, we made more noise than usual (and more than we’d like) by making public our idea for General Motors Company (NYSE:GM) to unlock tens of billions of dollars of shareholder value. As a general matter, we prefer to avoid public activism. The last time we did this was with AAPL in 2013 after owning the stock for three years. This is a similar situation; we had owned GM shares for years before advancing our idea to management.

    When we offer companies private advice, they either take it, or they explain why they are not going to take it. Usually if they reject the idea, we understand the reasoning and prefer not to press the issue. Sometimes, we agree to disagree, and then decide whether to hold the stock or exit the position.


  • David Einhorn Comments on Perrigo

    Perrigo (NYSE:PRGO) is the largest manufacturer of private label over -the-counter (OTC) pharmaceutical products for U.S. retailers and pharmacy chains. Over the past decade the company acquired other business lines, including a portfolio of European OTC brands (Omega), a generics pharmaceutical business, and a royalty stream on a large multiple sclerosis drug that has since been divested. In November 2015, shareholders rejected a hostile takeover offer from Mylan worth $175 per share after the then-CEO laid out ambitious standalone earnings targets. Unfortunately for shareholders, these targets proved far too optimistic and the CEO ultimately departed. After several large guidance cuts, we believe the new management team has now set achievable earnings forecasts. Omega’s business suffered from large restructuring expenses last year that should not recur and has additional margin upside as it streamlines its product portfolio. The company also has a dominant market position in its core U.S. OTC business and should continue to grow profits in this segment. We believe the U.S. OTC business and Omega have profit and growth characteristics similar to consumer products businesses, which trade at healthy multiples due to the stability of their cash flows. We purchased PRGO at an average price of $68.81 per share or 11x our estimate of 2019 earnings. PRGO shares ended the quarter at $66.39.


  • David Einhorn Comments on Xerox

    Xerox (NYSE:XRX) spun out its business process outsourcing segment as Conduent (NYSE:CNDT) at the end of 2016. CNDT provides transaction and back-office processing for a variety of government and commercial clients. We believe CNDT is burdened with underearning contracts it can renegotiate or exit. Some business units that have been run as loss leaders can evolve to be profit centers, and management is in the process of running off other unprofitable business units. Management has also initiated a $700 million cost savings plan to further improve margins. Despite the current revenue headwinds as the business is restructured, management has committed to growing revenue by the end of 2018 and beyond, and they are incentivized to improve earnings. We purchased CNDT at an average entry price of $14.76 per share, which represents 11x our conservative case estimate for 2019 earnings. The stock ended the quarter at $16.78.


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat